- Home
- XRTX vs TTNP Comparison
XRTX vs TTNP Comparison
Compare XRTX & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- TTNP
- Stock Information
- Founded
- XRTX 2011
- TTNP 1991
- Country
- XRTX Canada
- TTNP United States
- Employees
- XRTX N/A
- TTNP N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XRTX Health Care
- TTNP Health Care
- Exchange
- XRTX Nasdaq
- TTNP Nasdaq
- Market Cap
- XRTX 3.0M
- TTNP 3.4M
- IPO Year
- XRTX N/A
- TTNP 1996
- Fundamental
- Price
- XRTX $0.92
- TTNP $3.56
- Analyst Decision
- XRTX
- TTNP
- Analyst Count
- XRTX 0
- TTNP 0
- Target Price
- XRTX N/A
- TTNP N/A
- AVG Volume (30 Days)
- XRTX 84.2K
- TTNP 58.5K
- Earning Date
- XRTX 05-09-2025
- TTNP 03-31-2025
- Dividend Yield
- XRTX N/A
- TTNP N/A
- EPS Growth
- XRTX N/A
- TTNP N/A
- EPS
- XRTX N/A
- TTNP N/A
- Revenue
- XRTX N/A
- TTNP N/A
- Revenue This Year
- XRTX N/A
- TTNP N/A
- Revenue Next Year
- XRTX N/A
- TTNP N/A
- P/E Ratio
- XRTX N/A
- TTNP N/A
- Revenue Growth
- XRTX N/A
- TTNP N/A
- 52 Week Low
- XRTX $0.82
- TTNP $3.03
- 52 Week High
- XRTX $5.81
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- XRTX 42.89
- TTNP 41.17
- Support Level
- XRTX $0.85
- TTNP $3.81
- Resistance Level
- XRTX $1.10
- TTNP $4.39
- Average True Range (ATR)
- XRTX 0.11
- TTNP 0.47
- MACD
- XRTX 0.00
- TTNP -0.08
- Stochastic Oscillator
- XRTX 11.63
- TTNP 10.42
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.